AstraZeneca PLC August 2025 Form 6-K: Major Voting Rights Acquisition Insights

Based on the extracted content from the financial report, here are the key insights:

1. Form Type: The document is a Form 6-K, which is used by foreign companies to report to the SEC.
2. Company Information:

• Name: AstraZeneca PLC
• Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom
• SEC Commission File Number: 001-11960

3. Report Date: The report is for the month of August 2025.
4. Notification of Major Holdings:

• The notification indicates an acquisition or disposal of voting rights.

5. Shareholder Information:

• Entity Subject to Notification: The Capital Group Companies, Inc.
• Location: Los Angeles, USA.

6. Voting Rights:

• Threshold Date Crossed: August 8, 2025.
• Notification Date: August 11, 2025.
• Total Voting Rights Held: 77,294,699 shares.
• Percentage of Voting Rights: 4.984560%.

7. Previous Notification Position: The previous reported percentage of voting rights was 5.000629%.
8. Additional Shareholder Details: The shares reported are owned by accounts under the discretionary investment management of The Capital Group Companies, Inc. and its affiliates.
9. Ultimate Controlling Entity: The ultimate controlling person is also identified as The Capital Group Companies, Inc., which has several controlled undertakings.
10. Completion Details:

• Date of Completion of Notification: August 11, 2025.
• Place of Completion: Los Angeles.

11. Signatory: The document is signed by Matthew Bowden, Company Secretary.

This report highlights significant changes in voting rights that could impact governance and control within AstraZeneca PLC, revealing the active management and investment strategies of The Capital Group Companies, Inc.